(1/n) A brief #tweetorial highlighting the key aspects of our recent paper in #Cancer Discovery ⁦@CD_AACR⁩ on how cancers with #Chromosomal_Instability evade immune surveillance prompting #metastasis #ScienceTwitter cancerdiscovery.aacrjournals.org/content/early/…
We’ve previously shown that CIN can drive #metastasis through the generation of chronic #inflammation arising from persistent activation of #cGAS #STING signaling. However it wasn’t clear how cells eschewed the immune stimulating effect of this pathway. nature.com/articles/natur…
To address this, we compared isogenic cells with high vs. low levels of CIN and found that cells with high levels of CIN upregulated #ENPP1 an extracellular enzyme shown by @lingyinli1 and Tim Mitchison to hydrolyze #cGAMP
When we stained for #ENPP1 we found it selectively upregulated on both the protein and mRNA level in different models. Even within a tumor, cells that have invaded the lymph nodes exhibit higher membrane staining of ENPP1
A transmembrane protein with an extracellular catalytic domain, #ENPP1 selectively degrades #cGAMP in the extracellular space: its loss increased extracellular cGAMP whereas over-expression of WT - but not the catalytically inactive mutant - reduced extracellular cGAMP
We asked whether extracellular cGAMP hydrolysis enables cancer cells with chronic CIN and #cGAS activation to evade the immune stimulators effects of cGAMP. Indeed #ENPP1 loss led to reduced metas is whereas it’s overexpression in two separate models promoted metastasis
This was only the case when we overexpressed WT but not catalytically dead mutant of #ENPP1 and this was dependent on the presence of #STING in host cells, supporting the notion that ENPP1 disrupts tumor-to-host cGAMP transfer
We next asked whether cGAMP hydrolysis can be a source of adenosine. To our great surprised loss of #cGAS or #ENPP1 led to 40% reductions in extracellular adenosine suggesting that in addition to #ATP, #cGAMP can be a meaningful source of extracellular adenosine
Not surprisingly KO of #ENPP1 led to a significant increase in tumor immune infiltration which we think is due to the simultaneous activation of host #STING and reductions in extracellular #Adenosine
Importantly, loss of #ENPP1 in #immunotherapy resistant tumors restored their responsiveness to immune checkpoint blockade whereas its addition to sensitive tumors rendered them resistant
We next stained for #ENPP1 protein expression in nearly 500 human cancers and found conspicuous expression in metastasis particularly in lymph node metastases
#breastcancer one is the immunotherapy resistant tumor tumor types had widespread #ENPP1 expression with 65% of triple negative and ~90% of ER+ tumors showing moderate or strong staining and it was prognostic and dependent on tumor #cGAS expression
#ENPP1 expression was inversely correlated with tumor infiltrating lymphocytes and associated with metastasis in triple negative breast cancer
we think #ENPP1 is an important therapeutic target in cancers with chromosomal instability as well as a potential biomarker for immunotherapy response esp in breast cancer. Using a simple trick #cancer can transform immune stimulatory cGAMP into immune suppressor adenosine
Thanks to the AMAZING team in the lab led by the talented Jun Li and Mercedes Duran, great collaborators @BizarMd @eileen_parkes and finding sources @NIH_CommonFund @theNCI @BWFUND @PICIatMSK
Finally thank you to the @sloan_kettering news team for highlighting our work mskcc.org/news/taking-st…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Samuel Bakhoum

Samuel Bakhoum Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!